EUVIMEDEUVIMED entdecken
Crossref

Comparative Genomics and Pangenome Analysis of L. paracasei ATA-LTC-Lp121000 strain: A Potential Probiotic from Türkiye

Halil Kurt

Fabad Journal of Pharmaceutical Sciences · 30.10.2026 · 51 (3) · 1353-1372

DOI: 10.55262/fabadeczacilik.2019262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fabad Journal of Pharmaceutical Sciences, online erschienen am 30.10.2026. Verfasst von Halil Kurt. Die Arbeit nennt 1 Literaturangaben. Gefördert von: No fund was recıved for this study.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The isolation of novel Lacticaseibacillus strains with robust safety validation, technological stability, and specialized metabolic capabilities is crucial for advancing functional food and precision pharmabiotic industries. Since they are generally accepted as safe, many L. paracasei strains are suitable for use as probiotics. The aim of our study is to investigate the probiotic potential of the L. paracasei ATA-LTC-Lp121000 strain through in-depth genomic analyses and pan-genomic analyses of this strain against other closely related strains.A multi-dimensional probiogenomic workflow was executed on a novel Lacticaseibacillus isolate. Intraspecific pangenome dynamics, genomic stability, safety markers, and secondary metabolome signatures, including Carbohydrate-Active enZymes (CAZymes) and ribosomally synthesized and post-translationally modified peptides (RiPPs) were mapped across 30 distinct strains of the same species.Genotypic profiling verified the complete absence of transmissible antimicrobial resistance (AMR) genes and virulence factors. Pangenome mapping revealed an open pangenome architecture. L. paracasei ATA-LTC-Lp121000 isolate demonstrated exceptional chromosomal stability driven by a remarkably low density of mobile genetic elements (MGEs), specifically sparse IS30, IS5, and IS3 insertion sequences. Functional exploration revealed a rich enzymatic profile dominated by Hydrolase (GH1) and Glycoside Hydrolase families (GH13, GH25, and GH29, paired with RiPP biosynthetic gene clusters (BGCs).The novel Lacticaseibacillus isolate seamlessly combines absolute biosecurity clearance and superior genomic resistance to industrial mutational drift with premium targeted antimicrobial and prebiotic assimilation profiles. These combined traits establish the isolate as a highly secure, predictable, and elite raw material for next-generation biotherapeutics and functional food formulations.

Förderung

  • No fund was recıved for this study

Zitieren

APA

Kurt, H. (2026). Comparative Genomics and Pangenome Analysis of L. paracasei ATA-LTC-Lp121000 strain: A Potential Probiotic from Türkiye. Fabad Journal of Pharmaceutical Sciences, 51(3), 1353-1372. https://doi.org/10.55262/fabadeczacilik.2019262

Vancouver

Kurt H. Comparative Genomics and Pangenome Analysis of L. paracasei ATA-LTC-Lp121000 strain: A Potential Probiotic from Türkiye. Fabad Journal of Pharmaceutical Sciences. 2026;51(3):1353-1372. doi:10.55262/fabadeczacilik.2019262

BibTeX
@article{Kurt2026,
  author = {Kurt, Halil},
  title = {Comparative Genomics and Pangenome Analysis of L. paracasei ATA-LTC-Lp121000 strain: A Potential Probiotic from Türkiye},
  journal = {Fabad Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {51},
  number = {3},
  pages = {1353--1372},
  doi = {10.55262/fabadeczacilik.2019262}
}
Kostenlos starten →